Research study Program year 2023 Source: CMS Open Payments

214346

Research payments

$6,330,270

21 payments

Through program year 2023, $6,330,270 in research payments was reported against 214346, across 21 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$2,036,680	6
2022	Research	$3,235,983	12
2020	Research	$1,057,607	3

Breakdown

Who paid Research payments · program years 2020–2023

GlaxoSmithKline, LLC. $6,330,270 21 payments

Who received the money Research payments · program years 2020–2023

Translational Research In Oncology-US Organisation paid for research $6,330,270 21 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Jonathan Goldman Los Angeles, CA Named on 21 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.